![fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA](https://thehill.com/wp-content/uploads/sites/2/2023/11/654bf4321d7969.11613537-e1705002282406.jpeg?strip=1&w=640)
fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA
USD24.57
USD45.57
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
![fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA](https://static.wixstatic.com/media/60489a_95b142b425f4416b99f8a052fde88da7~mv2.jpg/v1/fill/w_980,h_551,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/60489a_95b142b425f4416b99f8a052fde88da7~mv2.jpg)
![fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA](https://www.statnews.com/wp-content/uploads/2023/11/Zepbound1-645x645.jpg)
![fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA](https://www.datocms-assets.com/66750/1763693863-zepbound_bottle.png?auto=format&fit=max&w=1200)
![fda to reconsider tirzepatide will decision barring copycat versions of Lilly weight loss drug UPDATE [March 7, 2025]: OFA](https://www.statnews.com/wp-content/uploads/2020/11/GettyImages-1227710576-645x645.jpg)
